Biomarkers In Cancer: Recent Advances | 6041
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Biomarkers in Cancer: Recent Advances

International Conference & Exihibition On Analytical and Bioanalytical Techniques - 2010

Sarasija Suresh

ScientificTracks Abstracts: J Anal Bioanal Techniques

DOI: 10.4172/2155-9872.1000001

Biomarkers are invaluable tools for cancer detection, diagnosis, patient prognosis and selection of treatment. In cancer research and treatment, assay of biomarker can be used to identify the presence of tumour, determine its stage, subtype and ability to respond to treatment. Further, biomarkers in cancer can be used to better understand tumour formation and to develop new therapeutic approaches. Despite years of intensive analysis only a small number of plasma proteins have been validated as cancer biomarkers such as prostate specific antigen and cancer antigen125. Now with technological advances in gene expression, genomic and proteomic analysis discovery of biomarkers is a fast growing area of cancer research. Development of genomics and proteomics has made it possible to monitor a large number of cellular pathways simultaneously. This has enabled the identification of biomarkers and signalling molecules associated with cell growth, cell death and cellular metabolism. Further, they are facilitating in monitoring the functional disturbances, molecular and cellular damage and damage response. This talk aims to describe some of the development of biomarkers in cancer research and detection with emphasis on different genomic and proteomic tools for the identification and discovery of new biomarkers including gene expression signatures associated with cancer cells which can tell us about cancer pathogenesis, progression and help in identifying patients who are most likely to respond to treatment and �single cell proteomics� to further understand tumorigenesis and work towards personalized treatment strategies.